Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen

Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen - ANRS 111 trial

Published:2009-08 Issue:4 Volume:23 Page:491-500
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:

Author:

Duval Xavier,Mentré France,Rey Elisabeth,Auleley Solange,Peytavin Gilles,Biour Michel,Métro Annie,Goujard Cecile,Taburet Anne-Marie,Lascoux Cecile,Panhard Xaviere,Tréluyer Jean-Marc,Salmon-Céron Dominique,

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1472-8206.2009.00693.x/fullpdf

Reference30 articles.

1. Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies;Chene;Lancet,2003

2. Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals;Duvivier;Antivir. Ther.,2003

3. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection;Walmsley;N. Engl. J. Med.,2002

4. Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial;Mannheimer;J. Acquir. Immune Defic. Syndr.,2006

5. Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy;Duval;Clin. Infect. Dis.,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions of Antiretroviral Drugs with Food, Beverages, Dietary Supplements, and Alcohol: A Systematic Review and Meta-analyses;AIDS and Behavior;2022-11-01

2. Development and validation of simplified RP-HPLC method for quantification of Darunavir in commercial tablets;Materials Today: Proceedings;2021

3. Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients;Expert Review of Clinical Pharmacology;2016-09-23

4. A pharmacist’s role in the individualization of treatment of HIV patients;Personalized Medicine;2016-03

5. Dynamical models of biomarkers and clinical progression for personalized medicine: The HIV context;Advanced Drug Delivery Reviews;2013-06